Literature DB >> 26843006

The effects of DAT1 genotype on fMRI activation in an emotional go/no-go task.

Brenna K Brown1, Jill Murrell2, Harish Karne3, Amit Anand4.   

Abstract

Dopaminergic brain circuits participate in emotional processing and impulsivity. The dopamine transporter (DAT) modulates dopamine reuptake. A variable number tandem repeat (VNTR) in the dopamine transporter gene (DAT1) affects DAT expression. The influence of DAT1 genotype on neural activation during emotional processing and impulse inhibition has not been examined. Forty-two healthy subjects were classified as 9DAT (n = 17) or 10DAT (n = 25) based on DAT1 genotype (9DAT = 9R/9R and 9R/10R; 10DAT = 10R/10R). Subjects underwent fMRI during non-emotional and emotional go/no-go tasks. Subjects were instructed to inhibit responses to letters, happy faces, or sad faces in separate blocks. Accuracy and reaction time did not differ between groups. Within group results showed activation in regions previously implicated in emotional processing and response inhibition. Between groups results showed increased activation in 9DAT individuals during inhibition. During letter inhibition, 9DAT individuals exhibited greater activation in right inferior parietal regions. During sad inhibition, 9DAT Individuals exhibited greater activation in frontal, posterior cingulate, precuneus, right cerebellar, left paracentral, and right occipital brain regions. The interaction between DAT genotype and response type in sad versus letter stimuli showed increased activation in 9DAT individuals during sad no-go responses in the anterior cingulate cortex, extending into frontal-orbital regions. 9DAT individuals have greater activation than 10DAT individuals during neutral and sad inhibition, showing that genotypic variation influencing basal dopamine levels can alter the neural basis of emotional processing and response inhibition. This may indicate that 9R carriers exert more effort to overcome increased basal dopamine activation when inhibiting responses in emotional contexts.

Entities:  

Keywords:  Dopamine transporter; Emotion; Response inhibition

Mesh:

Substances:

Year:  2017        PMID: 26843006      PMCID: PMC4972696          DOI: 10.1007/s11682-016-9516-7

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  34 in total

1.  The human prefrontal and parietal association cortices are involved in NO-GO performances: an event-related fMRI study.

Authors:  Jobu Watanabe; Motoaki Sugiura; Kazunori Sato; Yuko Sato; Yasuhiro Maeda; Yoshihiko Matsue; Hiroshi Fukuda; Ryuta Kawashima
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

2.  Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans.

Authors:  Adam R Aron; Paul C Fletcher; Ed T Bullmore; Barbara J Sahakian; Trevor W Robbins
Journal:  Nat Neurosci       Date:  2003-02       Impact factor: 24.884

3.  The interaction of emotional and cognitive neural systems in emotionally guided response inhibition.

Authors:  Keith M Shafritz; Susan H Collins; Hilary P Blumberg
Journal:  Neuroimage       Date:  2006-02-09       Impact factor: 6.556

4.  The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression.

Authors:  S Fuke; S Suo; N Takahashi; H Koike; N Sasagawa; S Ishiura
Journal:  Pharmacogenomics J       Date:  2001       Impact factor: 3.550

5.  Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample.

Authors:  K M Cornish; T Manly; R Savage; J Swanson; D Morisano; N Butler; C Grant; G Cross; L Bentley; C P Hollis
Journal:  Mol Psychiatry       Date:  2005-07       Impact factor: 15.992

Review 6.  Functional hyperdopaminergia in dopamine transporter knock-out mice.

Authors:  R R Gainetdinov; S R Jones; M G Caron
Journal:  Biol Psychiatry       Date:  1999-08-01       Impact factor: 13.382

7.  Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

Authors:  Jonathan Mill; Philip Asherson; Clare Browes; Ursula D'Souza; Ian Craig
Journal:  Am J Med Genet       Date:  2002-12-08

8.  Variation in dopamine genes influences responsivity of the human reward system.

Authors:  Jean-Claude Dreher; Philip Kohn; Bhaskar Kolachana; Daniel R Weinberger; Karen Faith Berman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

9.  Predictors of impulsivity and reward seeking behavior with dopamine agonists.

Authors:  William G Ondo; Dejian Lai
Journal:  Parkinsonism Relat Disord       Date:  2007-08-16       Impact factor: 4.891

10.  Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects.

Authors:  Xavier Caldú; Pere Vendrell; David Bartrés-Faz; Inmaculada Clemente; Núria Bargalló; María Angeles Jurado; Josep Maria Serra-Grabulosa; Carme Junqué
Journal:  Neuroimage       Date:  2007-07-04       Impact factor: 6.556

View more
  2 in total

1.  miR-137 and miR-491 Negatively Regulate Dopamine Transporter Expression and Function in Neural Cells.

Authors:  Xiaojian Jia; Feng Wang; Ying Han; Xuewen Geng; Minghua Li; Yu Shi; Lin Lu; Yun Chen
Journal:  Neurosci Bull       Date:  2016-09-15       Impact factor: 5.203

2.  Prevalence of Some Genetic Risk Factors for Nicotine Dependence in Ukraine.

Authors:  Vitalina Bashynska; Alexander Koliada; Kateryna Murlanova; Oksana Zahorodnia; Yuliia Borysovych; Vladyslav Moseiko; Oleh Lushchak; Alexander Vaiserman
Journal:  Genet Res Int       Date:  2019-10-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.